Flecainide suppresses an arrhythmogenic substrate in Andersen-Tawil syndrome-induced pluripotent stem cell-derived cardiomyocytes

29 August 2016 (16:39 - 16:48)
Organised by:
Congress Presentation Part of: Stem cells and cell therapy Stem cells and cell therapy ESC Premium Access ESC Congress 2016